Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ads free!Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ads free today!Spring sale! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

Gilead Sciences
Biotech
Topics

Advertisement

Gilead Sciences

Share

Top Latest Popular

In the last 5 minutes

California Justices Scrutinize Gilead Patients’ Liability Theory Bloomberg Law 22:16

In the last 2 hours

California's highest court leans toward Gilead in considering drugmakers' 'duty to innovate' The Charlotte Observer 20:36

In the last 4 hours

Fourth Circuit Skeptical of ‘Gray Market’ Drug Import Vendors Bloomberg Law 20:14

Advertisement

Advertisement

Earlier Today

California's highest court to consider whether drugmakers have 'duty to innovate' The Charlotte Observer 11:26

Earnings To Watch: Gilead Sciences (GILD) Reports Q1 Results Tomorrow Barchart 04:40

Yesterday

Gilead Fights ‘Limitless’ Liability at California High Court Bloomberg Law 15:00 Tue, 05 May

Clio Health Champions: Jenny Yun, Senior Director, U.S. HIV Prevention Marketing – Gilead Sciences Muse by Clio 13:51 Tue, 05 May

Use of Gilead's HIV prevention shot rises, but US insurance gaps remain The Tribune, California 11:30 Tue, 05 May

Monday

Curious about Gilead (GILD) Q1 Performance? Explore Wall Street Estimates for Key Metrics Zacks 15:21 Mon, 04 May

The “Duty to Innovate” Arrives at the California Supreme Court: Oral Argument Set for May 6, 2026 Drug & Device Law 10:03 Mon, 04 May

Advertisement

Saturday

PrEP4All sues federal government over 2025 HIV prevention research agreement Gay City News 17:42 Sat, 02 May

Friday

The Freelux Project Announces “The Butch Queen’s Brunch & Conversations Tour” Powered by Gilead Sciences GLAAD 16:44 Fri, 01 May

Gilead Sciences to Present at Upcoming Second Quarter 2026 Investor Conferences Business Wire (Press Release) 11:04 Fri, 01 May

Gilead Advances HIV And Oncology Pipeline As Shares Trade Below Targets Simply Wall St 06:56 Fri, 01 May

Thursday

Gilead Sciences (GILD) Outperforms Broader Market: What You Need to Know Zacks 23:50 Thu, 30 Apr

Gilead Sciences Stock Outlook: Is Wall Street Bullish or Bearish? Barchart 16:32 Thu, 30 Apr

Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know Zacks 15:10 Thu, 30 Apr

In the last month

U.S. FDA Grants Priority Review of New Drug Application for Gilead’s Once-Daily HIV Treatment of Bictegravir Plus Lenacapavir Business Wire (Press Release) 13:34 Wed, 29 Apr

STAT Plus: AIDS group sues Trump administration over undisclosed agreement with Gilead STAT 23:21 Tue, 28 Apr

Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel Business Wire (Press Release) 13:46 Tue, 28 Apr

Gilead’s pipeline strategy in 2026: A broadening focus beyond HIV Labiotech 14:07 Mon, 27 Apr

This pharma company makes a miracle HIV drug, but is blocking access for millions of low-income people The Guam Daily Post 07:34 Mon, 27 Apr

Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts Zacks 23:55 Fri, 24 Apr

Relative Strength Alert For Gilead Sciences Nasdaq 21:27 Fri, 24 Apr

The Generation to End HIV: Empowered College Leaders and Queer Storytellers Deliver Lifesaving Message to GenZ in HBCU Campus Tour GLAAD 17:44 Fri, 24 Apr

Gilead Sciences to Release First Quarter 2026 Financial Results on Thursday, May 7, 2026 Business Wire (Press Release) 21:05 Wed, 22 Apr

What's Going On With Arcus Biosciences Stock On Wednesday? Benzinga 20:23 Wed, 22 Apr

South Africa: Who Controls South Africa's Lenacapavir Rollout? Not South Africa AllAfrica 05:51 Wed, 22 Apr

Bristol Myers vs Gilead Sciences: Which Biotech Stock Is a Better Bet Now? Zacks 17:32 Tue, 21 Apr

Gilead Sciences (GILD) Declines More Than Market: Some Information for Investors Zacks 00:01 Tue, 21 Apr

Gilead Leans Further Into Oncology With Arcellx And Tubulis Deals Simply Wall St 06:49 Sun, 19 Apr

How Investors Are Reacting To Gilead Sciences (GILD) Expanding No‑Profit Lenacapavir Access Globally Simply Wall St 18:41 Fri, 17 Apr

Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer Business Wire (Press Release) 13:39 Fri, 17 Apr

Beam Hits Peak As Gilead Lab Hub Rises Over Vintage Park Hoodline 21:02 Thu, 16 Apr

iShares Core High Dividend ETF Experiences Big Outflow Nasdaq 16:33 Thu, 16 Apr

Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It Zacks 15:09 Thu, 16 Apr

Lenacapavir and the Long Road from ‘Miracle’ to Global Access Observer Research Foundation 11:36 Thu, 16 Apr

Gilead is not doing enough to expand access to groundbreaking HIV prevention medicine Doctors Without Borders (Press Release) 20:10 Wed, 15 Apr

US-Led Partnership To Provide 1 Mln Lenacapavir To Help End HIV Transmission RTT News 12:02 Wed, 15 Apr

Here's Why Gilead Sciences (GILD) Gained But Lagged the Market Today Zacks 00:04 Wed, 15 Apr

Advertisement

Advertisement

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Business Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna